Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q2 2023 Earnings Call Transcript

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q2 2023 Earnings Call Transcript August 9, 2023

Xenon Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.72 EPS, expectations were $0.69.

Operator: Good afternoon ladies and gentlemen, and thank you for standing by. Welcome to the Xenon Pharmaceuticals Report, Second Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. [Operator instructions]. I will now turn the call over to Sherry...